Skip to content
OpenCapital
Get started

Lexeo Therapeutics, Inc. LXEO Q1 2026 earnings

Reported May 11, 2026 · Before market open

EPS-$0.25Beat by $0.04
EPS estimate-$0.29

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$0.30

Versus estimates

Diluted EPS

Q1 2026-$0.25Beat by $0.04
Q4 2025-$0.27Beat by $0.05Q3 2025-$0.33Beat by $0.15Q2 2025-$0.60Beat by $0.04Q1 2025-$0.99Miss by $0.19Q4 2024-$0.78Beat by $0.09

Ask the moment Lexeo Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Lexeo Therapeutics, Inc. report Q1 2026 earnings?
Lexeo Therapeutics, Inc. (LXEO) reported Q1 2026 earnings on May 11, 2026 before market open.
What were Lexeo Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Lexeo Therapeutics, Inc. reported eps of $-0.25 for Q1 2026.
Did Lexeo Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.29 by $0.04.
How did Lexeo Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 74.7% from $-0.99.
Where can I find Lexeo Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-215674) and the 10-Q periodic report (0001193125-26-215678) directly on SEC EDGAR. The filing index links above go to sec.gov.